Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Peijia Medical Ltd. (HK:9996)
HKEX:9996
Holding HK:9996?
Track your performance easily
9996 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$2.16 - HK$8.34
Previous CloseHK$3.88
Volume1.05M
Average Volume (3M)1.36M
Market Cap
HK$2.59B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.21
Next Earnings
Mar 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.40
Shares OutstandingN/A
10 Day Avg. Volume379,700
30 Day Avg. Volume1,359,983
Standard Deviation0.20
R-Squared0.21
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)28.33
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$3.99Price Target Upside2.92% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Peijia Medical Ltd. News
PremiumCompany Announcements
Peijia Medical Advances with TAVR System in Hong Kong
PremiumCompany Announcements
Peijia Medical Announces Resignation of Non-Executive Director
PremiumCompany Announcements
Peijia Medical Unveils Board Structure and Governance
PremiumCompany Announcements
Peijia Medical Shareholders Greenlight Key Resolutions
PremiumCompany Announcements
Peijia Medical Schedules Annual General Meeting
PremiumCompany Announcements
Peijia Medical Corrects AGM Documentation ErrorsPremiumCompany Announcements
Peijia Medical Ltd. Gears Up for Annual General Meeting
PremiumCompany Announcements
Peijia Medical Announces Auditor ChangeOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.38% Mutual Funds
― Other Institutional Investors
99.60% Public Companies and
Individual Investors
9996 FAQ
What was Peijia Medical Ltd.’s price range in the past 12 months?
Peijia Medical Ltd. lowest stock price was HK$2.16 and its highest was HK$8.34 in the past 12 months.
What is Peijia Medical Ltd.’s market cap?
Currently, no data Available
When is Peijia Medical Ltd.’s upcoming earnings report date?
Peijia Medical Ltd.’s upcoming earnings report date is Mar 27, 2025 which is in 123 days.
How were Peijia Medical Ltd.’s earnings last quarter?
Peijia Medical Ltd. released its earnings results on Aug 23, 2024. The company reported -HK$0.107 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.107.
Is Peijia Medical Ltd. overvalued?
According to Wall Street analysts Peijia Medical Ltd.’s price is currently Undervalued.
Does Peijia Medical Ltd. pay dividends?
Peijia Medical Ltd. does not currently pay dividends.
What is Peijia Medical Ltd.’s EPS estimate?
Peijia Medical Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Peijia Medical Ltd. have?
Peijia Medical Ltd. has 668,517,800 shares outstanding.
What happened to Peijia Medical Ltd.’s price movement after its last earnings report?
Peijia Medical Ltd. reported an EPS of -HK$0.107 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.175%.
Which hedge fund is a major shareholder of Peijia Medical Ltd.?
Currently, no hedge funds are holding shares in HK:9996
---
Peijia Medical Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-48.04%
12-Months-Change
Fundamentals
Return on Equity
-10.94%
Trailing 12-Months
Asset Growth
-5.96%
Trailing 12-Months
Company Description
Peijia Medical Ltd.
Peijia Medical Ltd is focused on the interventional procedural, transcatheter valve therapeutic and the neurointerventional procedural medical device market in China. The company's product candidates include Transcatheter Aortic Valve Replacement products,Transcatheter Mitral Valve Replacement/Transcatheter Tricuspid Valve Replacement products, Ancillary products, and Neurointerventional products. Its operating segments are Transcatheter Valve Therapeutic Business and Neurointerventional Business.
---
9996 Stock 12 Month Forecast
Average Price Target
HK$3.99
▲(2.92% Upside)
Technical Analysis
Best Analysts Covering 9996
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-2.60%
reiterated a buy rating 3 months ago
Copying Alexis Yan's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -2.60% per trade.
---